# Plasmalyte Versus Saline in Trauma Patients

> **NCT03630224** · PHASE3 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 365 (actual)

## Conditions studied

- Severe Trauma Patients
- Acute Kidney Injury

## Interventions

- **DRUG:** Plasmalyte Viaflo
- **DRUG:** NaCl 0.9%

## Key facts

- **NCT ID:** NCT03630224
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-24
- **Primary completion:** 2023-08-18
- **Final completion:** 2023-08-18
- **Target enrollment:** 365 (ACTUAL)
- **Why stopped:** Premature termination due to futility following interim analysis
- **Last updated:** 2024-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03630224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03630224, "Plasmalyte Versus Saline in Trauma Patients". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03630224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*